|
USP33 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.12399999999224E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.562330E-04 |
| Normal-vs-Stage2 |
1.329580E-01 |
| Normal-vs-Stage3 |
2.585700E-04 |
| Normal-vs-Stage4 |
3.42129999997276E-06 |
| Stage1-vs-Stage2 |
5.378600E-01 |
| Stage1-vs-Stage3 |
5.492000E-01 |
| Stage1-vs-Stage4 |
1.880570E-01 |
| Stage2-vs-Stage3 |
3.672400E-01 |
| Stage2-vs-Stage4 |
2.124800E-01 |
| Stage3-vs-Stage4 |
5.631800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.00799999999979E-05 |
| Normal-vs-AfricanAmerican |
4.75010000000609E-06 |
| Normal-vs-Asian |
2.490600E-01 |
| Caucasian-vs-AfricanAmerican |
8.145500E-02 |
| Caucasian-vs-Asian |
2.907600E-02 |
| AfricanAmerican-vs-Asian |
2.016600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.83830000023111E-07 |
| Normal-vs-Female |
9.836200E-03 |
| Male-vs-Female |
1.280330E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.601600E-04 |
| Normal-vs-Age(41-60Yrs) |
9.411100E-04 |
| Normal-vs-Age(61-80Yrs) |
6.14279999999745E-05 |
| Normal-vs-Age(81-100Yrs) |
3.782500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.519800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.522800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.529200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.478200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.741400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.134600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.142600E-01 |
| Normal-vs-Grade 2 |
5.129600E-02 |
| Normal-vs-Grade 3 |
6.62790000660607E-09 |
| Normal-vs-Grade 4 |
2.11250017478903E-10 |
| Grade 1-vs-Grade 2 |
5.191600E-01 |
| Grade 1-vs-Grade 3 |
1.607760E-02 |
| Grade 1-vs-Grade 4 |
4.629400E-04 |
| Grade 2-vs-Grade 3 |
3.026900E-04 |
| Grade 2-vs-Grade 4 |
7.19880000055184E-07 |
| Grade 3-vs-Grade 4 |
4.630000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.065600E-01 |
| Normal-vs-ccB subtype |
6.37109999979124E-07 |
| ccA subtype-vs-ccB subtype |
4.38390000001565E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.198800E-04 |
| Normal-vs-N1 |
2.129500E-02 |
| N0-vs-N1 |
6.797600E-01 |
|
|
